About: Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2008 (ast) vědecký článek publikovaný v roce 2008 (cs) 2008 թվականի հոտեմբերին հրատարակված գիտական հոդված (hy) 2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в жовтні 2008 (uk) مقالة علمية (نشرت في أكتوبر 2008) (ar) vedecký článok (publikovaný 2008/10/01) (sk) wetenschappelijk artikel (gepubliceerd op 2008/10/01) (nl) im Oktober 2008 veröffentlichter wissenschaftlicher Artikel (de) scientific journal article (en)
publication date	wds:Q28570302-826C00FD-BBC6-43A2-99D9-8089B7E2A3AA
publication date	2008-10-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q28570302-00C53CEC-AA92-4507-9509-70FB6685A51D wds:Q28570302-08DE0809-CF75-4D52-A921-7CD79292338C wds:Q28570302-136FB48E-3C3F-4394-9967-169C8CD7B855 wds:Q28570302-1707A69E-D5F5-4B5A-988B-55FF6CCA89CD wds:Q28570302-1F967613-44E7-4798-A051-384A22BF9A88 wds:Q28570302-29A9EE13-025D-43A6-8691-C53A0EEBD04E wds:Q28570302-32E3E03C-FC32-4900-9793-09E9AB5BE5A3 wds:Q28570302-56C8F2B3-89EF-437E-BAEF-54B97E46C8CC wds:Q28570302-5CCD13DD-1681-4CF6-B0EF-D4D046DA65C8 wds:Q28570302-5CDE22B6-747C-4977-B00A-F4C49494A69A wds:Q28570302-6E1B872A-BD00-4A1D-B173-8983C548F3FE wds:Q28570302-6F68CC9C-EDFB-4EA0-8AF4-44A742FE9077 wds:Q28570302-763FA95E-DE62-48F5-96F4-C5F12C9BAFAE wds:Q28570302-7FD083F3-6AEB-4EE4-BF2E-91B11CD7BD1D wds:Q28570302-8CA60541-68D9-4A11-8A00-19F69A08F3AE wds:Q28570302-8E9B5131-10E6-4861-ACC8-7BA20DAF9364 wds:Q28570302-92DA515E-752D-4C8C-881E-B77F9B2ED986 wds:Q28570302-9478AC15-E8B8-4AB7-B05D-D00E65F34D2A wds:Q28570302-9C91418F-F3F9-4455-83C8-F5E559508BF9 wds:Q28570302-A7135B03-777E-44EA-A6C4-402B743C8D9E wds:Q28570302-ACD4B868-651F-4161-8658-799542F45DFA wds:Q28570302-AD9890A3-7BDD-4536-B949-F44DA6DEE984 wds:Q28570302-AE447974-86E8-43FB-AF95-C5121BD0945B wds:Q28570302-BD6CF350-4AF3-4668-B89C-64B06A02BCEB wds:Q28570302-C419BCD5-7825-4B50-B75A-02EA8F784C28 wds:Q28570302-D07C7758-C26F-42F0-9A78-10D255E7DDE8 wds:Q28570302-D2C5775C-9242-4128-ABA5-B0BAEFEFD512 wds:Q28570302-D8013B67-27EC-46FF-AB8A-62A38A315CDC wds:Q28570302-DC3870C9-4776-4212-B524-E4D4781C7FB9 wds:Q28570302-F244566C-EFE1-4D77-9441-00DAA8B0D583 wds:Q28570302-F34232C9-90B5-4899-B8BA-72DB58850A01 wds:Q28570302-F515874E-81B3-443B-8BD2-AEA42E44DA10 wds:Q28570302-F8C1BA17-9768-4E50-A3ED-A2A3BF837241 wds:Q28570302-FAAF81CC-C3C7-4BDF-BF88-EEB4B7F19619
cites work	Inhibition of NF-kappa B by sodium salicylate and aspirin Aspirin and platelet function Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin The mechanism of action of aspirin Potential cardioprotective actions of no-releasing aspirin Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity. Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: genomic, mRNA, and protein sequences with comparisons to other species Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis High-density lipoproteins and atherosclerosis Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins Resveratrol: from grapevines to mammalian biology Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice PPARalpha activation potentiates AhR-induced CYP1A1 expression Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation Aspirin and other cyclooxygenase inhibitors: new therapeutic insights Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1 Oxidative inactivation of paraoxonase--implications in diabetes mellitus and atherosclerosis Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2 Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil The pharmacokinetics of aspirin in rats and the effect of buffer. Systemic availability of acetylsalicylic acid in human subjects after oral ingestion of three different formulations
author name string	wds:Q28570302-4764ECC2-9C34-4566-8DF9-C2FB1C6C0582 wds:Q28570302-A8259D5D-179E-4D8F-B918-31D20BA2AF86 wds:Q28570302-BEF86464-FFBA-4CD8-998F-9E9884BD4270 wds:Q28570302-EF462885-7E3D-4BBE-9633-391DEE784FB2
author name string	Sampath Parthasarathy Mahdi Garelnabi Priscilla Jaichander Krithika Selvarajan
rdfs:label	Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (en) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (nl) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (ast)
skos:prefLabel	Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (en) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (nl) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (ast)
name	Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (en) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (nl) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (ast)
title	wds:Q28570302-CEC0172D-C59C-4E4E-B2D9-85C71A2A8401
title	Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software